MY189736A - Methods for detecting pathogenicity of ganoderma sp. - Google Patents

Methods for detecting pathogenicity of ganoderma sp.

Info

Publication number
MY189736A
MY189736A MYPI2020001649A MYPI2020001649A MY189736A MY 189736 A MY189736 A MY 189736A MY PI2020001649 A MYPI2020001649 A MY PI2020001649A MY PI2020001649 A MYPI2020001649 A MY PI2020001649A MY 189736 A MY189736 A MY 189736A
Authority
MY
Malaysia
Prior art keywords
ganoderma
methods
detecting
pathogenicity
markers
Prior art date
Application number
MYPI2020001649A
Inventor
Peck Lei Cheong
Sue Sean Tee
Eng Piew Kok
Mei Ling Chong
Weng Wah Lee
Suan Choo Cheah
Original Assignee
Acgt Sdn Bhd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acgt Sdn Bhd filed Critical Acgt Sdn Bhd
Publication of MY189736A publication Critical patent/MY189736A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6895—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention generally relates to markers that can be used for detecting Ganoderma species. The present invention also relates to use of the markers in methods of screening and determining pathogenicity of a Ganoderma species, such as Ganoderma boninense (G. boninense), Ganoderma steyaertanum and Ganoderma orbiforme.
MYPI2020001649A 2017-12-14 2018-03-01 Methods for detecting pathogenicity of ganoderma sp. MY189736A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MYPI2017001860 2017-12-14
PCT/MY2018/050010 WO2019117704A1 (en) 2017-12-14 2018-03-01 Methods for detecting pathogenicity of ganoderma sp.

Publications (1)

Publication Number Publication Date
MY189736A true MY189736A (en) 2022-02-28

Family

ID=62620919

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2020001649A MY189736A (en) 2017-12-14 2018-03-01 Methods for detecting pathogenicity of ganoderma sp.

Country Status (2)

Country Link
MY (1) MY189736A (en)
WO (1) WO2019117704A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113063863A (en) * 2021-03-16 2021-07-02 中国热带农业科学院环境与植物保护研究所 Marker for identifying ganoderma curvatum and product thereof and application of marker
CN112980998B (en) * 2021-04-27 2022-05-03 广东省科学院微生物研究所(广东省微生物分析检测中心) Molecular marker, specific primer and identification method of high-quality ganoderma leucocontextum strain I140033

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG189821A1 (en) 2011-10-31 2013-06-28 Felda Agricultural Services Sdn Bhd Markers for ganoderma disease diagnosis and a use of thereof
MY170201A (en) 2013-01-14 2019-07-09 Sime Darby Plantation Berhad A method for identifying a ganoderma-infected palm tree

Also Published As

Publication number Publication date
WO2019117704A1 (en) 2019-06-20

Similar Documents

Publication Publication Date Title
MX2018010362A (en) Methods and systems for evaluating tumor mutational burden.
EA201990566A1 (en) COMPOSITIONS CONTAINING BACTERIAL STRAINS
MX2019007020A (en) Il-11 antibodies.
MX2021004479A (en) Biologicals and their use in plants.
PH12018500711A1 (en) Anti-pd1 antibodies and methods of use
MX2015000193A (en) Private information hiding method and device.
MX2019005199A (en) Methods for assessing risk using total and specific cell-free dna.
MX2017003478A (en) Anti-fgfr2/3 antibodies and methods using same.
CA2961701C (en) Method and system for determining the local quality of surface data extracted from volume data
WO2016077381A8 (en) Anti-interleukin-33 antibodies and uses thereof
EP4335874A3 (en) Anti-hla-g antibodies and use thereof
MX2017016169A (en) Anti-her2 antibodies and methods of use.
WO2016061456A3 (en) Compositions and methods for identification, assessment, prevention, and treatment of t-cell exhaustion using cd39 biomarkers and modulators
SG10201808259TA (en) Anti-jagged1 antibodies and methods of use
MX2016004865A (en) Social relationship analysis method and device.
MX2019000088A (en) Compositions and methods for detecting and treating diabetes.
MX363352B (en) Apparatus and method for generating an enhanced signal using independent noise-filling.
MX2021007245A (en) Microorganism for producing putrescine or ornithine and method for producing putrescine or ornithine by using same.
MY191539A (en) Streptococcal vaccine
TN2017000435A1 (en) [bis(trihydrocarbylsilyl)aminosilyl]-functionalized styrene and a method for its preparation
WO2016023991A8 (en) Method for microbiom analysis
MX2019010643A (en) Forms and compositions of a mk2 inhibitor.
MX2021000530A (en) Method for preparing c-h acidic (meth)acrylates.
TN2018000197A1 (en) Compositions and methods for assessing the risk of cancer occurrence
MX2019006090A (en) Methods of enhancing immune response with everolimus, dactolisib or both.